Discovery of Novel DUSP16 Phosphatase Inhibitors through Virtual Screening with Homology Modeled Protein Structure. (December 2014)

• Record Type: Journal Article
• Authors: Park, Hwangseo; Park, So Ya; Nam, Sang-Won; Ryu, Seong Eon
• Is Part Of: Journal of biomolecular screening. Volume 19:Number 10(2014)
• Page Start: 1383
• Page End: 1390
• Publication Date: 2014-12
• Subjects: cheminformatics -- computational chemistry -- enzyme assays -- medicinal chemistry; Drugs -- Analysis -- Periodicals; Drugs -- Testing -- Periodicals; Biomolecules -- Analysis -- Periodicals; 572.36
• DOI: 10.1177/1087057114550784
• Languages: English
• ISSNs: 1087-0571

Abstract

Recently, dual-specificity phosphatase 16 (DUSP16) emerged as a promising therapeutic target protein for the development of anti-atherosclerosis and anticancer medicines. The present study was undertaken to identify the novel inhibitors of DUSP16 based on the structure-based virtual screening. We have been able to find seven novel inhibitors of DUSP16 through the drug design protocol involving homology modeling of the target protein, docking simulations between DUSP16 and its putative inhibitors with the modified scoring function, and in vitro enzyme assay. These inhibitors revealed good potency, with IC50 values ranging from 1 to 22 µM, and they were also screened computationally for having desirable physicochemical properties as drug candidates. Therefore, they deserve consideration for further development by structure-activity relationship studies to optimize the inhibitory activity against DUSP16. Structural features relevant to the stabilization of the newly identified inhibitors in the active site of DUSP16 are addressed in detail.